   Thomas Kearns | FibroGen Inc | ZoomInfo.com

Thomas F. Kearns Jr.: Executive Profile & Biography - Bloomberg









































  





















































































July 23, 2017 10:13 PM ET
Biotechnology

Company Overview of FibroGen, Inc.



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Thomas F. Kearns Jr.Director, FibroGen, Inc.AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 4 different industries.See Board Relationships80$195,465
Background

		Mr. Thomas F. Kearns, Jr. was a Partner of Bear Stearns & Co. Inc., until 1987. Mr. Kearns has been a Director of Fibrogen, Inc since November 1996. Mr. Kearns serves as a Director of Fibrogen Corp. and Omega Institute. He serves as Trustee of the University of North Carolina Foundation and Endowment Fund. Mr. Kearns served as a Director of On-Gard Systems, Inc., since December 24, 1995. He served as a Director of PharmaKinetics Laboratories, Inc. and Biomet Inc., at ... Kirschner Medical Corporation.Read Full Background




Corporate Headquarters
409 Illinois StreetSan Francisco, California 94158United StatesPhone: 415-978-1200Fax: 415-978-1902
Board Members Memberships
1996-PresentDirectorFibroGen, Inc.
Education
BA University of North Carolina
Other Affiliations
Biomet, Inc.BASi Maryland, Inc.On-Gard Systems, Inc.Kirschner Medical CorporationUniversity of North Carolina


Annual Compensation
				There is no Annual Compensation data available.
				Stocks Options
				There is no Stock Options data available.
				Total Compensation
Total Annual Cash Compensation$58,106Total Calculated Compensation$195,465




Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONNamePosition/CompanyCompensationDavid A. Ricks Chairman, Chief Executive Officer & PresidentEli Lilly and Company--Compensation as of Fiscal Year --.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact FibroGen, Inc., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close





























Insider Trading - Kearns Thomas F Jr - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Kearns Thomas F Jr





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-11-17Sale
2016-11-187:11 pm
Fibrogen Inc
FGEN
Kearns Thomas F JrDirector
18,000
$22.4
$403,160
173,564(IndirectDirect)
View


2016-01-21Sale
2016-01-227:18 pm
Fibrogen Inc
FGEN
Kearns Thomas F JrDirector
1,572
$22.08
$34,710
160,564(IndirectDirect)
View


2015-12-23Sale
2015-12-286:41 pm
Fibrogen Inc
FGEN
Kearns Thomas F JrDirector
7,800
$30.88
$240,825
166,036(IndirectDirect)
View


2015-11-23Sale
2015-11-255:27 pm
Fibrogen Inc
FGEN
Kearns Thomas F JrDirector
7,800
$28.51
$222,389
173,836(IndirectDirect)
View


2015-10-20Sale
2015-10-226:51 pm
Fibrogen Inc
FGEN
Kearns Thomas F JrDirector
7,800
$23.83
$185,903
182,436(IndirectDirect)
View




Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-11-17Exercise
2016-11-187:11 pm
N/AN/A
Fibrogen Inc
FGEN
Kearns Thomas F JrDirector
5,000
$4.025
173,564(Direct)
View


2016-11-17Exercise
2016-11-187:11 pm
N/AN/A
Fibrogen Inc
FGEN
Kearns Thomas F JrDirector
13,000
$4.025
173,564(Direct)
View


2016-11-17Exercise
2016-11-187:11 pm
N/A2017-08-19
Fibrogen Inc
FGEN
Kearns Thomas F JrDirector
5,000
$4.025
173,564(Direct)
View


2016-11-17Exercise
2016-11-187:11 pm
N/A2017-08-19
Fibrogen Inc
FGEN
Kearns Thomas F JrDirector
7,000
$4.025
173,564(Direct)
View


2016-11-17Exercise
2016-11-187:11 pm
N/A2017-08-19
Fibrogen Inc
FGEN
Kearns Thomas F JrDirector
6,000
$4.025
173,564(Direct)
View


2016-06-08Option Award
2016-06-106:38 pm
N/A2026-06-08
Fibrogen Inc
FGEN
Kearns Thomas F JrDirector
12,000
$19.05
12,000(Direct)
View


2015-06-03Option Award
2015-06-056:16 pm
N/A2025-06-02
Fibrogen Inc
FGEN
Kearns Thomas F JrDirector
12,000
$18.34
12,000(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Sun, 23 Jul 2017 21:13:19 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  








  Fibrogen Inc (FGEN) Files Form 4 Insider Selling : Thomas F Jr Kearns  Sells  18,000 Shares – Energy Index          Search       Fibrogen Inc (FGEN) Files Form 4 Insider Selling : Thomas F Jr Kearns  Sells  18,000 Shares       Kevin Winslow    June 12, 2017         Fibrogen Inc (FGEN): Thomas F Jr Kearns , director of Fibrogen Inc  sold 18,000 shares on Jun 6, 2017. The Insider selling transaction was reported by the company on Jun 8, 2017 to the Securities and Exchange Commission. The shares were sold at $28.71 per share for a total value of $516,780.00  , the company said in a SEC Form 4 Filing.Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 1, 2017, Thomas B Neff  (Chief Executive Officer) sold 38,636 shares at $26.27 per share price.On May 17, 2017, Kalevi Kurkijarvi  (director) sold 2,000 shares at $27.40 per share price.Also, On May 12, 2017, K Peony Yu  (Chief Medical Officer) sold 5,000 shares at $26.57 per share price.On Apr 27, 2017, Pat Cotroneo  (VP, Finance and CFO) sold 6,500 shares at $28.00 per share price.Shares of FibroGen Inc (FGEN) ended Tuesday, May 30, 2017 session in red amid volatile trading. The shares closed down -1.5 points or -5.50% at $25.75 with 4,90,613 shares getting traded. Post opening the session at $27.25, the shares hit an intraday low of $25.7 and an intraday high of $27.465 and the price vacillated in this range throughout the day. The company has a market cap of $1,801 M and the number of outstanding shares has been calculated to be 6,99,44,209 shares. The 52-week high of FibroGen Inc is $29 and the 52-week low is $14.5.FibroGen Inc. is a research-based biopharmaceutical company. The Company is focused on the discovery development and commercialization of therapeutic agents. Its lead product candidate is roxadustat or FG-4592 is an oral small molecule inhibitor of hypoxia inducible factor-prolyl hydroxylase (HIF-PHs) in Phase III clinical development for the treatment of anemia in chronic kidney disease (CKD). The Company’s second product candidate FG-3019 is a monoclonal antibody in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis (IPF) pancreatic cancer and liver fibrosis. Roxadustat is a HIF-PH inhibitor that acts by stimulating the body’s natural pathway of erythropoiesis or red blood cell production. FG-5200 is a corneal implant. Its product FG-3019 blocks FG-3019 blocks CTGF (CTGF). FG-6874 is a HIF-PH inhibitor. FG-8205 is in preclinical evaluation for use as a cardioprotective agent to prevent the onset of heart failure following a heart attack.     Kevin WinslowTo contact the author of this report, send an email to  kevin.winslow@energyindexwatch.comYou might also likeBankfinancial Corp (BFIN) Files Form 4 Insider Selling : Paul A Cloutier  Sells  10,000 Shares Bankfinancial Corp (BFIN): Paul A Cloutier ,…Opko Health, Inc. (OPK) Files Form 4 Insider Buying : Gamma Investments Trust Frost  Buys  1,800 Shares Opko Health, Inc. (OPK): Gamma Investments Trust…Chesapeake Energy Corp (CHK) Files Form 4 Insider Buying : R Brad Martin  Buys  20,400 Shares Chesapeake Energy Corp (CHK): R Brad Martin…Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *   Previous Post1347 Property Insurance Holdings, Inc. (PIH) Files Form 4 Insider Buying : Douglas N Raucy  Buys  1,791 Shares Next PostWal Mart Stores Inc (WMT) Files Form 4 Insider Selling : S Robson Walton  Sells  3,221,265 Shares Latest Earning ReleasesThe Big Earnings of Chipotle Mexican Grill Were Overshadowed by the Data BreachDespite its Sales Spiraling Down H&M Launches a New Label- ArketRevenue Update on AdCare Health Systems(NYSEMKT:ADK)Revenue Update on Eleven Biotherapeutics Inc(NASDAQ:EBIO)     The Demand for Cloud and SSD Are Now the Prime Growth Engines for Micron As WellAlaska Airlines Planning to Absorb Virgin America by 2019Andrew Puzder Decides to Leave CKE Restaurants HoldingsSoftbank Goes Soft on Wework and Invests $300 MillionMore Departures in Uber as Two Executives LeaveVolkswagen and Audi Headquarters Raided by German Authorities      








Thomas F. Kearns Jr. - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In



















Thomas F. Kearns Jr.
Board Member at FibroGen, Inc.


View Full Profile
Are you Thomas F. Kearns Jr.? Claim your profile


 


Sign up for Equilar Atlas and view Thomas F. Kearns Jr.'s full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in Thomas F. Kearns Jr.'s  network and community.
												FOLLOW changes in Thomas F. Kearns Jr.'s employment and money-in-motion.
												CONNECT with Thomas F. Kearns Jr. through your network of contacts.
												








Thomas F. Kearns Jr.'s Executive Work History


Current


Board Member, 
FibroGen, Inc.


Past
To view Thomas F. Kearns Jr.'s complete executive work history, sign up now
Age
80

 
 


Thomas F. Kearns Jr.'s Biography



Thomas F. Kearns Jr., age 80, has served on our board of directors since November 1996. Mr. Kearns is a retired Partner of The Bear Stearns Companies Inc., an investment banking firm, where he was an investment banker in the healthcare area from 1974 until 1987. Prior to his career at Bear Stearns, Mr. Kearns worked for Merrill Lynch, an investment banking firm, from January 1959 until August 1969. Mr. Kearns is Chairman of the National Advisory Board of Carolina Performing Arts at the University of North Carolina. In 2013, he joined the board of directors of Franklin Street Partners. Mr. Kearns was a Trustee of the University of North Caroli ...
(Read More)

			Thomas F. Kearns Jr., age 80, has served on our board of directors since November 1996. Mr. Kearns is a retired Partner of The Bear Stearns Companies Inc., an investment banking firm, where he was an investment banker in the healthcare area from 1974 until 1987. Prior to his career at Bear Stearns, Mr. Kearns worked for Merrill Lynch, an investment banking firm, from January 1959 until August 1969. Mr. Kearns is Chairman of the National Advisory Board of Carolina Performing Arts at the University of North Carolina. In 2013, he joined the board of directors of Franklin Street Partners. Mr. Kearns was a Trustee of the University of North Carolina Foundation and Endowment Fund for 16 years and served on the board of directors of Biomet Inc. from January 1980 until May 2005. He received his B.A. in History from the University of North Carolina. We believe that Mr. Kearns is qualified to serve on our board of directors due to his financial expertise stemming from a career in investment banking with a focus on the healthcare industry.
		
Source: FibroGen, Inc. on 04/24/2017
		
	

 






Sign up for Equilar Atlas and view Thomas F. Kearns Jr.'s full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like Thomas F. Kearns Jr.. More specifically, you'll be able to:
												

IDENTIFY corporate executives in Thomas F. Kearns Jr.'s  network and community.
												FOLLOW changes in Thomas F. Kearns Jr.'s employment and money-in-motion.
												CONNECT with Thomas F. Kearns Jr. through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: Thomas F. Kearns Jr.


















Thomas F. Kearns Jr.'s Connections (43)





Sign up now to view Thomas F. Kearns Jr.'s 43 connections »









Julian N. Stern
Former Board Member, FibroGen, Inc.









Jeffrey W. Henderson
Board Member, Qualcomm









James A. Schoeneck
Dir., President and Chief Executive Officer, Depomed, Inc.









Garry L. England
Former Chief Operating Officer - Domestic Operations, Biomet









Bradley J. Tandy
Former Senior Vice President, General Counsel and Secretary, Biomet, Inc., Biomet









Charles E. Niemier
Former Senior Vice President and Senior Vice President, Biomet International and Corporate Relations, Biomet









Rory B. Riggs
Board Member, FibroGen, Inc.









Roger P. van Broeck
Former Senior Vice President; President of Biomet Europe, Middle East and Africa, Biomet









Daniel P. Hann
Former Senior Vice President, Business Development, Biomet









Jorma Routti
Former Board Member, FibroGen, Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Elon R. Musk
CEO and Chairman, Tesla









Daniel A. DeMatteo
Executive Chairman, GameStop Corp.









David J. O'Connor
President and CEO, The Madison Square Garden Company












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

� 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993























Kearns Thomas F Jr - Insider Stock Trading - OpenInsider











Sector

All Sectors

Group by Sector


Aerospace
Agriculture
Automobile
Building
Business Services
Chemical
Electrical
Energy
Fashion
Financial
Food & Beverage
Fund
Healthcare
Household
Insurance
Machinery
Media
Metals
Mining
Other
Personal Services
Real Estate
Retail
Technology
Telecom
Transportation
Utility




Industry

All Industries

Group by Industry






Insiders
Filings


All
Purchases
Sales

CIK: 1189184 - Address: C/o Fibrogen, Inc., 409 Illinois St., San Francsico, CA 94158 10 results 

						Links
						


SECYahooGoogleFinvizTradingViewStockChartsStockTwitsDownload CSV 













TC
Stat
Stk
Ins
Fil
+d
+w
+m
+q
+h
+y
avg


S%ret11521-6-14-26-12-9S%wins202060801007559 




Filing Date
T Date
Ticker
IssuerInc Sector
IndIndustry
Owner
oSt
Rel
Title
T
TVal
Price
L
Qty
oc
Own
H
r2y
r1y
r6m
r3m
r6w
r3w
r7d
r3d
f1d
f1w
f1m
f3m
f6m
f1y



6/8/17 19:516/6/17FGENFibrogen IncDEHealthDrugPharmaceutical PreparationsKearns Thomas F JrCADM.d1769.780188249D
6/8/17 19:516/6/17FGENFibrogen IncDEHealthDrugPharmaceutical PreparationsKearns Thomas F JrCADS.d-51728.710-18-7249D
11/18/16 19:1111/17/16FGENFibrogen IncDEHealthDrugPharmaceutical PreparationsKearns Thomas F JrCADM.dm724.0314187271D-5-182522123542401-146
11/18/16 19:1111/17/16FGENFibrogen IncDEHealthDrugPharmaceutical PreparationsKearns Thomas F JrCADS.dm-40322.4014-18-6271D-5-182522123542401-146
1/22/16 19:181/21/16FGENFibrogen IncDEHealthDrugPharmaceutical PreparationsKearns Thomas F JrCADS-3522.0812-2-1271D-36-16-14-33-34-18-91-10-7-3-1523
12/28/15 18:4112/23/15FGENFibrogen IncDEHealthDrugPharmaceutical PreparationsKearns Thomas F JrCADS.m-24130.8816-8-3272D1327252325441-35-33-49-30
11/25/15 17:2711/23/15FGENFibrogen IncDEHealthDrugPharmaceutical PreparationsKearns Thomas F JrCADS.m-22228.5113-8-3280D27602943111311125-38-37-22
10/22/15 18:5110/20/15FGENFibrogen IncDEHealthDrugPharmaceutical PreparationsKearns Thomas F JrCADS.m-18623.839-8-3288D-15-5-16810731322-3-4-17
1/8/07 17:011/5/07BMETBiomet IncINHealthOrthopOrthopedic, Prosthetic & SurgKearns Thomas F JrCTDM.d7135.70021912D
4/15/04 16:034/15/04BMETBiomet IncINHealthOrthopOrthopedic, Prosthetic & SurgKearns Thomas F JrCTDM.d10927.1604799D



DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing



S - SaleSale of securities on an exchange or to another person

S - Sale+OESale of securities on an exchange or to another person (after option exercise)

F - TaxPayment of exercise price or tax liability using portion of securities received from the company

P - PurchasePurchase of securities on an exchange or from another person


Return to top
Contact
Copyright © 2017 OpenInsider.com. All rights reserved.







Director of FibroGen (NASDAQ:FGEN), Kearns Thomas F Jr, sells 18,000 shares worth 6,780








































Stay Connected

Latest Posts in RSS

BusinessEntertainmentFeatured NewsFeatured Press ReleaseFinanceHealthLifestyleNationNon FirstPageOriginalPress ReleaseReviewShoppingSportsStocksTechnologyTravelWorld


Latest Comments in RSS


 / 













EmpoweredNews
World News Summary Helping You Stay Informed









Business
Finance
Sports
Entertainment
Health
Technology
Travel
Shopping




Our Writers
About Us
Privacy Policy
Contact Us
Advertise
Press Releases
















Director of FibroGen (NASDAQ:FGEN), Kearns Thomas F Jr, sells 18,000 shares worth $516,780
According to FibroGen's most recent Form 4 filing with the SEC dated Jun 08 07:51 PM, company Director, Kearns Thomas F Jr disclosed selling 18,000 shares at a cost of $28.71. At the time of this transaction (Jun 06), this trade was worth $516,780 in total. As of Jun 06, Kearns Thomas F Jr now owns 138,564 shares in total worth about $4,039,140.6. 
For the last few recent trades made by FibroGen (NASDAQ:FGEN) Director, Kearns Thomas F Jr, we have the following information:




SEC Form 4 filing: Nov 17: Sold 5,000 shares at the rate of $22.21 per share. Total worth of this trade was $111,028. Total number of shares owned as of Nov 17 were 160,564
SEC Form 4 filing: Nov 18: Sold 13,000 shares at the rate of $22.47 per share. Total worth of this trade was $292,132. Total number of shares owned as of Nov 18 were 160,564
SEC Form 4 filing: Dec 23: Sold 3,900 shares at the rate of $30.94 per share. Total worth of this trade was $120,666. Total number of shares owned as of Dec 23 were 166,036




					Posted by  



George Daniels 

					
					on Thursday June 08 2017, 10:01 PM EDT. 

All trademarks acknowledged. 
Filed under Stocks.

	Comments and Trackbacks closed.	
 Follow responses: 
RSS 2.0




Comments are closed


 Latest News 
EVP, CL&AO of Vertex Pharmaceuticals Incorpor (NASDAQ:VRTX), Parini Michael, sells 10,829 shares worth $1,743,469
CEO & President of Vertex Pharmaceuticals Incorpor (NASDAQ:VRTX), Leiden Jeffrey M, sells 184,374 shares worth $29,684,214
EVP GMDA, CMO of Vertex Pharmaceuticals Incorpor (NASDAQ:VRTX), Chodakewitz Jeffrey, sells 39,833 shares worth $6,413,113
EVP, Global Research and CSO of Vertex Pharmaceuticals Incorpor (NASDAQ:VRTX), Altshuler David, sells 28,979 shares worth $4,665,619
EVP\Chief Commercial Officer of Vertex Pharmaceuticals Incorpor (NASDAQ:VRTX), Arbuckle Stuart A, sells 89,400 shares worth $14,441,830
See Remarks of Aimmune Therapeutics (NASDAQ:AIMT), Sheehy Douglas T., sells 7,460 shares worth $161,558
SVP and General Counsel of NxStage Medical (NASDAQ:NXTM), Swan Winifred L, sells 3,500 shares worth $84,560
Chief Product Officer of Facebook (NASDAQ:FB), Cox Christopher K, sells 16,000 shares worth $2,628,483
Founder & Executive Chairman of Ellie Mae (NYSE:ELLI), Anderman Sigmund, sells 1,319 shares worth $144,958
Chief Financial Officer of Civitas Solutions (NYSE:CIVI), Holler Denis M., sells 5,300 shares worth $101,230

 


News Categories 
Business (7)

Stocks (15,219)



Entertainment (1,297)

Featured News (3,487)

Featured Press Release (250,644)

Finance (309)

Health (653)

Lifestyle (19)

Nation (90)

Non FirstPage (2)

Original (47)

Press Release (18)

Review (1)

Shopping (267)

Sports (613)

Technology (195)

Travel (286)

World (1,368)


  Featured Press Releases 
Global ECG (Electrocardiogram) Monitoring Equipment Sales Industry Report:  Sales Volume Market Share by Type and Application
Global Curling Equipments Sales Industry Report:  Sales Volume Market Share by Type and Application
Global Diagnostics PCR Sales Market Sales Volume (Million Units) and Growth Rate (2012-2022) Analysis in a Latest Research Report
Global Concrete Saw Sales Market Sales Volume (Million Units) and Growth Rate (2012-2022) Analysis in a Latest Research Report
Global Direct Water Dispensers Sales Industry Report:  Sales Volume Market Share by Type and Application
Global ECG (Electrocardiogram) Monitoring Equipment Sales Industry Report:  Sales Volume Market Share by Type and Application
Global Dual Voltage Comparator Sales Industry Report:  Sales Volume Market Share by Type and Application
Global Contact Prober Sales Industry Report:  Sales Volume Market Share by Type and Application
Global CT Contrast Injectors Sales Industry Report:  Sales Volume Market Share by Type and Application
Global Counter-IED Equipments Sales Industry Report:  Sales Volume Market Share by Type and Application







Business
Finance
Sports
Entertainment
Health
Technology
Travel
Shopping
 

About Us
Contact Us
Privacy Policy
Advertise
Press Releases
Terms Of Service
 
Log in 














Thomas F Kearns: Veromi's People Search and Business Directory
























People SearchBackground CheckCriminal CheckPeople DirectoryBusiness DirectoryAll ProductsWhy Veromi



The Trusted Information Source


Login

Search

Help


















Find Person: Thomas F Kearns.


Veromi People Index: NOW WITH BUSINESS DATA. The most comprehensive People Database in the World.









Start your search now!




Name
Address
Phone







First Name:



Middle Initial: 



Last Name: 






Approx. Age:





City:




State:


Select state...
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
Washington DC
West Virginia
Wisconsin
Wyoming










Address:



Zip:






City:




State:


Select a state...
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
Washington DC
West Virginia
Wisconsin
Wyoming















Phone Number:

























Search Results for 
 Thomas F Kearns



We found 45 people that match 
Thomas F Kearns 
.





Person


Ageapprox


Has lived in


Possible Relationships


Information Available








Kearns Iii, Thomas F

Possible Aka's:
Kearns, Thomas F

Find out more



53


Three Rivers, MA





Kearns, Jean A

Kearns, Iii Thomasf



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas E

Possible Aka's:
Kearns, Thomas F
Kearns, Thomas I
Kearns, Thomas S

Find out more



73


Cape Canaveral, FL
Maywood, NJ
Cocoa, FL
Cocoa Beach, FL
Merritt Island, FL
Fort Lauderdale, FL
Woodbury, NY





Kearns, Mildred T

Kearns, Cheryl Christen

Kearns, Kelly Mryan

Kearnsvoness, Hannelore

Kearns, D

Kearns, Ganielle H

Kearns, Christen C

Kearns, Colleen

Kearns, Danielle H



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F

Possible Aka's:
Kearns, Thos F

Find out more



94


Fall River, MA





Kearns, Irene M



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas T

Possible Aka's:
Kearns, Thos
Kearns, Thomas F
Kearnstom

Find out more



54


Norcross, GA
Rehoboth, MA
Midlothian, VA
Ashburn, VA
Charlotte, NC
Arlington Heights, IL
Marietta, GA





Kearns, Susan K

Kearns, Tom F

Kearns, Susan K



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F




50


Maywood, NJ
Commack, NY
Charleston, SC
Cape Canaveral, FL
North Arlington, NJ
Brooklyn, NY
Cocoa Beach, FL





Kearns, Kelly Mryan

Kearns, Elizabeth F

Kearns, Janet F

Kearns, Colleen



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F

Possible Aka's:
Kearns, T

Find out more



53


Haskell, NJ
Butler, NJ
Hawthorne, NJ
Saddle Brook, NJ
Honesdale, PA





Davies, Luanne Ann

Kearns, James J

Kearns, Eric John

Kearns, Brian P

Kearns, Urssula B

Kearns, James J

Kearns, Matthew T

Kearns, Luanne



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F

Possible Aka's:
Kearnstom

Find out more



48


New York, NY





Kearns, Tom F

Kearns, Tom

Kearns, Michele

Kearns, Michelle



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns Jr, Thomas F

Possible Aka's:
Kearns, Thomas
Kearns, Thomas F
Kearns, Thomas F
Kearns, Thomas F Jr
Kearnst
Kearnsa, Thomas F

Find out more



55


Darien, CT
Brooklyn, NY
New York, NY
Warsaw, IN





Kearns, Caroline C

Kearns, Elizabeth Wright

Kearns, Elizabeth Wright

Kearns, Maryann H

Kearns, Margaret E

Nealon, Eilleen T

Kearns, Jr Thomasf

Kearns, Eileen T

Kearns, Thomas F



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F







Salt Lake Cty, UT
Salt Lake City, UT
Park City, UT
Pinedale, WY





Kearnscampbell, Genevieve T

Kearns, Jacqueline



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F

Possible Aka's:
Kearns, Thomas C

Find out more



79


Pittsburgh, PA







Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F




54


Leesburg, VA
Dunbar, WV
Uniontown, PA





Kearns, Dolores M

Kearns, Christopher C

Kearns, Melanie Bost



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F




63


Shamokin, PA







Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas E

Possible Aka's:
Kearns, Thomas F

Find out more



54


North Wildwood, NJ
Marlton, NJ
Philadelphia, PA
Wildwood, NJ





Baratta, Angela M

Kearns, John Xavier



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F

Possible Aka's:
Kearns, Tom

Find out more



100


Rolling Hills, CA
Ojai, CA
Redondo Beach, CA





Kearns, Patricia R

Kearns, Thomas

Kearns, Tom

Kearns, Ricia R



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F




95


Carlsbad, CA
Torrance, CA





Kearns, Mary S



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F

Possible Aka's:
Kerns, Thomas C
Kerns, Thomas F

Find out more



68


Alexandria, VA
Bealeton, VA
Culpeper, VA
Warrenton, VA





Kerns, Darold L

Kerns, Henry H

Kerns, Elizabeth A



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F




93


Arlington, VA





Kearns, Catherine P



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F

Possible Aka's:
Kearns, Thos F
Kerons, Thomas F

Find out more






Neshkoro, WI





Kearns, Barbara J

Kearns, Dorothy A

Kearns, Beatrice



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas M

Possible Aka's:
Kearns, Thomas F

Find out more



99


Fresno, CA





Kearns, Gregory P

Kearns, Rosalie C

Sweeneykearns, Deborah

Kearns, Jeffrey John

Kearns, Deborah A

Kearns, Patricia A

Kearns, Jeffrey J

Kearns, Deborah A



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Forest T

Possible Aka's:
Kearns, Thomas F
Kearns, F T T
Kearns, F T Ofc Res
Kearns, F T Res
Kearns, F Thomas

Find out more



69


Mount Clare, WV
Clarksburg, WV
Atlanta, GA





Kearns, Elexis Blair

Kearns, F Tofc



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F







Eugene, OR





Kearns, Jacqueline



Get Full Report

Report can contain

Profile
Address








Kearns, Thomas F







East Douglas, MA







Get Full Report

Report can contain

Profile
Address








Kearns, Thomas F




105


Rochester, NY







Get Full Report

Report can contain

Profile
Address








Kearns, Thomas F

Possible Aka's:
Keams, Thomas
Kearns, Thos F F

Find out more



93


Central Falls, RI





Kearns, Charlotte Couch

Kearns, Thomas M

Kearns, Tori B



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns Jr, Thomas F

Possible Aka's:
Kearns, Thomas F
Kearns, Thos F Jr

Find out more



59


Milton, PA





Kearns, Thelma M

Kearns, Thomas B

Kearns, Timothy

Kearns, Jr Thomasf



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F




77


Sandy Hook, CT





Kearns, James Pjr

Kearns, John E

Kearns, Alma D



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F




75


New York, NY





Kearns, Elizabeth Wright

Kearns, Elizabeth Wright



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F












Kearns, Dina T



Get Full Report

Report can contain

Profile








Kearns, Thomas F




30


Warren, MA







Get Full Report

Report can contain

Profile
Address








Kearns, Thomas F




64


Albany, NY







Get Full Report

Report can contain

Profile
Address








Kearns, Thomas F

Possible Aka's:
Kearns, Tom

Find out more



76


Jersey City, NJ







Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F

Possible Aka's:
Kearns, T
Kearns, Thos

Find out more



84


Brooklyn, NY





Nealon, Eilleen T

Kearnsjr, Thomas F

Kearns, Margaret E

Kearns, Maryann H

Kearns, Mary Annh

Kearns, Brendan J

Kearns, Patrick J



Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F







Greensboro, NC







Get Full Report

Report can contain

Profile
Address








Kearns, Thomas F







Cocoa Beach, FL





Kearns, Mildred T



Get Full Report

Report can contain

Profile
Address








Kearns, Thomas F







Merritt Island, FL







Get Full Report

Report can contain

Profile
Address








Kearns, Thomas F




86


Tarpon Springs, FL







Get Full Report

Report can contain

Profile
Phone number
Address








Kearns Iv, Thomas F

Possible Aka's:
Kearns, Thomas F

Find out more



61


Reno, NV







Get Full Report

Report can contain

Profile
Address








Kearns, Thomas F




38


Port Orchard, WA







Get Full Report

Report can contain

Profile
Address








Kearns, Thomas F




63


Shamokin, PA







Get Full Report

Report can contain

Profile
Address








Kearns, Thomas F







Albany, NY







Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F







Salt Lake City, UT







Get Full Report

Report can contain

Profile
Address








Kearns, Thomas F







Warsaw, IN







Get Full Report

Report can contain

Profile
Address








Kearns, Thomas F




54


Marlton, NJ





Kearns, Angela M



Get Full Report

Report can contain

Profile
Address








Kearns, Thomas F




77


Sandy Hook, CT







Get Full Report

Report can contain

Profile
Phone number
Address








Kearns, Thomas F







Fairburn, GA







Get Full Report

Report can contain

Profile
Address
















Copyright © 2007 - 2017
Veromi All rights reserved.



Login
| Search
| Bookmark
| Contact Us
| Terms & Conditions 
| Help
| Site Map
| People
| People Search Directory
| Articles
| Answering Service
| People Search













Insiders Selling, Short Interest Growing FibroGen, Inc (NASDAQ:FGEN) - Highlight Press

























































Highlight PressBreaking Tech News, Entertainment, Mortgages and More
Insiders Selling, Short Interest Growing FibroGen, Inc (NASDAQ:FGEN)
June 8, 2017 By Clarence Martin Tweet        Advertisement





Here is the rundown on market activity for FibroGen, Inc (NASDAQ:FGEN).   Director Thomas F. Jr Kearns sold 18,000 shares at an average price of $28.71 on Tue the 6th. Kearns now owns $3,978,172 of stock as reported to the SEC. Thomas B. Neff, CEO disclosed the sale of 38,636 shares. The shares sold for $26.27. The CEO now owns $3,635,295 of the stock according to the SEC filing.
 Kalevi Kurkijarvi, Director reported the sale of 2,000 shares of FGEN stock. The shares were sold on May 16th for an average price of $27.40. Kurkijarvi now owns $986,400 of the stock per the Form 4 SEC filing.
 FibroGen, Inc., launched on September 29, 1993, is a science-based biopharmaceutical company. The Company is involved in the discovery, development and commercialization of therapeutics to treat serious unmet medical needs. The Company focuses in the areas of fibrosis and hypoxia-inducible factor (HIF) biology and generates multiple programs targeting various therapeutic areas. The Business’s lead product candidate is roxadustat (FG-4592). It is also engaged in developing products, such as FG-6874, FG-3019 and FG-5200.. 
 Here are a few additional firms who have increased or decreased their stake in (FGEN).   Morgan Stanley divested its investment by selling 122 shares a decrease of 0.3% from 12/31/2016 to 03/31/2017. Morgan Stanley claims 36,813 shares with a value of $907,000. The total value of its holdings increased 14.8%. As of quarter end Ecor1 Capital, LLC had sold 644,175 shares trimming its stake by 93.9%. The value in dollars decreased from $14,684,000 to $1,036,000 a change of $13,648,000 for the reporting period.





 Goldman Sachs Group Inc grew its position by buying 105,590 shares an increase of 86.2% as of 03/31/2017. Goldman Sachs Group Inc now holds 228,062 shares worth $5,622,000. The value of the position overall is up by 114.5%. As of the end of the quarter Janus Capital Management LLC had acquired  a total of 14,882 shares growing its position 1.1%. The value of the investment in FibroGen, Inc went from $28,867,000 to $33,613,000 increasing 16.4% since the last quarter.
  On February 11 the stock rating was upgraded from “Neutral” to “Outperform” and a price target of $40.00 was set by analysts at Credit Suisse. Credit Suisse raised the price target and upgraded the stock on February 11 changing the price target from $29.00 to $40.00 and raising the rating from “Neutral” to “Outperform”.
 Equity analyst Credit Suisse began coverage by announcing an initial rating of “Neutral” and a price target of $29.00. Citigroup released its first research report on the stock with an initial rating of “Buy” and projecting a price target of $40.00.
 On July 29 analysts at Citigroup initiated coverage on FGEN giving it an initial rating of “Buy” and establishing a price target of $37.00. July 20 investment analysts at Goldman Sachs kept the price objective at $32.00 but boost the company from Neutral to Buy.
 In the market the company is trading up since yesterday’s close of $28.65.  Company shares last traded at $29.15 which is marginally over $27.47, the 50 day moving average and which is a tad above the 200 day moving average of $24.61.  The 50 day moving average was up by +6.12% and the 200 day average was up $4.54. 
 As of the last earnings report the EPS was $-1.06 and is estimated to be $-1.81 for the current year with 69,944,000 shares now outstanding.  Analysts expect next quarter’s EPS to be $-0.35 and the next full year EPS is projected to be $-0.85. 
 Short traders are more bearish on shares of FibroGen, Inc recently at least if you consider the increase in short interest.  The company experienced a rise in short interest between April 28, 2017 and May 15, 2017 of 19.01%.  Short interest grew from 1,973,719 to 2,348,987 over that period.  With short interest at 2,348,987 and short average daily volume at 482,714, days to cover is 4.9 and the percentage of shorted shares is 0.03% as of May 15.






         Advertisement






         Advertisement






 

Mortgage Rate Updates
Current  Mortgage Rates at Suntrust, Capital One Jul 23, 2017 … [Read More...]BB&T, PHH Mortgage Mortgage Interest Rates Up Jul 23, 2017BB&T BankThe best 30 year FRMs have been published at 4% at BB&T Corp. (NYSE:BBT) today … [Read More...]No Change in Mortgage Rates at Quicken Loans, US Bankcorp Sunday Jul 23, 2017Quicken LoansThe benchmark 30 year loans at Quicken Loans start at 3.125% and APR of … [Read More...]Wells, BMO Harris Bank Current  Mortgage Rates Sunday Jul 23, 2017Wells Fargo30 year FRMs at Wells Fargo (NYSE:WFC) stand at 4.000% and an APR of 4.050% … [Read More...]
Sports
Lonzo Ball’s Latest Footwear Has Well and Truly FloppedHere’s a question – would all the social media hype and celebrity endorsements in the world encourage you to spend $500 on a pair of basketball … [Read More...]Super Bowl Winners to Pocket $107,000 Per Player – Tax-Free!It’s long been known that the tax returns of professional athletes are just about as complex as it gets. This is because not only do they have to pay … [Read More...]
Top News
Business
Technology
Sports
Entertainment
Life
Mortgages
Also In the News…

About Us
Writers
Advertise With Us
Contact Us

 Reuters: Technology News
Madrid asks anti-trust watchdog to probe Uber's new airport serviceToyota eyes mass EV output in China as early as 2019: reportLyft accelerates efforts to develop self-driving cars

 Highlight Press is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to amazon.com.





Stock Screener - Yahoo FinanceHomeMailFlickrTumblrNewsSportsFinanceCelebrityAnswersGroupsMobileMoreYahooSearchSearch0U.S. Markets closedS&P 5002,472.54-0.91 (-0.04%)Dow 3021,580.07-31.71 (-0.15%)LISTENAetna's CEO Mark Bertolini on the future of the health care systemBertolini shares how a life-threatening injury shaped his views on health care.Insider TransactionsDefault CriteriaInsider & Restricted Shareholder Transactions1-13 of 13 resultsResults were generated a few mins ago. Pricing data is updated frequently. Currency in USDSymbolDateSharesProceedsTransaction DetailsFGEN2017-06-0518,000$516,780.00Sale at $28.71 per share.FGEN2017-06-0518,000$176,040.00Option Execute at $9.78 per share.FGEN2016-11-1713,000$52,390.00Option Execute at $4.03 per share.FGEN2016-11-1713,000$292,110.00Sale at $22.47 per share.FGEN2016-11-165,000$111,050.00Sale at $22.21 per share.FGEN2016-11-165,000$20,150.00Option Execute at $4.03 per share.FGEN2016-01-201,572$35,000.00Automatic Sale at $22.08 - $22.08 per share.FGEN2015-12-233,900$120,000.00Automatic Sale at $30.81 - $30.81 per share.FGEN2015-12-223,900$121,000.00Automatic Sale at $30.94 - $30.94 per share.FGEN2015-11-233,900$112,000.00Automatic Sale at $28.46 - $29.19 per share.FGEN2015-11-223,900$109,000.00Automatic Sale at $28.02 - $28.02 per share.FGEN2015-10-203,900$92,000.00Automatic Sale at $23.26 - $23.87 per share.FGEN2015-10-193,900$96,000.00Automatic Sale at $24.17 - $24.95 per share.How 2 life-threatening events changed how Aetna's CEO views health careYahoo FinanceJeb Bush calls out Republicans who criticized Obama over Russia, but have been silent on the Trump-Russia probeBusiness InsiderWhy sparkling water sales could spike by 20% in 2017Yahoo FinanceYahoo Small BusinessData DisclaimerHelpSuggestionsPrivacyAbout Our AdsTerms (Updated)





